nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP1A2—Sorafenib—thyroid cancer	0.111	0.277	CbGbCtD
Anastrozole—CYP2C9—Sorafenib—thyroid cancer	0.0999	0.249	CbGbCtD
Anastrozole—CYP3A4—Vandetanib—thyroid cancer	0.0964	0.241	CbGbCtD
Anastrozole—CYP3A4—Sorafenib—thyroid cancer	0.0581	0.145	CbGbCtD
Anastrozole—CYP3A4—Doxorubicin—thyroid cancer	0.0353	0.088	CbGbCtD
Anastrozole—Breast pain—Epirubicin—thyroid cancer	0.00171	0.00285	CcSEcCtD
Anastrozole—Ageusia—Doxorubicin—thyroid cancer	0.0017	0.00284	CcSEcCtD
Anastrozole—Vasodilation—Epirubicin—thyroid cancer	0.0017	0.00283	CcSEcCtD
Anastrozole—Vasodilation procedure—Epirubicin—thyroid cancer	0.0017	0.00283	CcSEcCtD
Anastrozole—Cardiovascular disorder—Epirubicin—thyroid cancer	0.0017	0.00283	CcSEcCtD
Anastrozole—Abdominal pain—Vandetanib—thyroid cancer	0.00169	0.00281	CcSEcCtD
Anastrozole—Body temperature increased—Vandetanib—thyroid cancer	0.00169	0.00281	CcSEcCtD
Anastrozole—Arthropathy—Epirubicin—thyroid cancer	0.00164	0.00273	CcSEcCtD
Anastrozole—Anaemia—Sorafenib—thyroid cancer	0.00163	0.00272	CcSEcCtD
Anastrozole—Cough increased—Epirubicin—thyroid cancer	0.00163	0.00271	CcSEcCtD
Anastrozole—Neoplasm malignant—Doxorubicin—thyroid cancer	0.00161	0.00269	CcSEcCtD
Anastrozole—Angioedema—Sorafenib—thyroid cancer	0.00161	0.00269	CcSEcCtD
Anastrozole—Breast pain—Doxorubicin—thyroid cancer	0.00158	0.00264	CcSEcCtD
Anastrozole—Leukopenia—Sorafenib—thyroid cancer	0.00158	0.00263	CcSEcCtD
Anastrozole—Ulcer—Epirubicin—thyroid cancer	0.00157	0.00263	CcSEcCtD
Anastrozole—Vasodilation—Doxorubicin—thyroid cancer	0.00157	0.00262	CcSEcCtD
Anastrozole—Vasodilation procedure—Doxorubicin—thyroid cancer	0.00157	0.00262	CcSEcCtD
Anastrozole—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00157	0.00262	CcSEcCtD
Anastrozole—Bone pain—Epirubicin—thyroid cancer	0.00156	0.00259	CcSEcCtD
Anastrozole—Cough—Sorafenib—thyroid cancer	0.00154	0.00257	CcSEcCtD
Anastrozole—Inflammation—Epirubicin—thyroid cancer	0.00154	0.00256	CcSEcCtD
Anastrozole—Asthenia—Vandetanib—thyroid cancer	0.00153	0.00255	CcSEcCtD
Anastrozole—Hypertension—Sorafenib—thyroid cancer	0.00152	0.00254	CcSEcCtD
Anastrozole—Arthropathy—Doxorubicin—thyroid cancer	0.00152	0.00253	CcSEcCtD
Anastrozole—Pruritus—Vandetanib—thyroid cancer	0.00151	0.00252	CcSEcCtD
Anastrozole—Neck pain—Epirubicin—thyroid cancer	0.00151	0.00252	CcSEcCtD
Anastrozole—Cough increased—Doxorubicin—thyroid cancer	0.00151	0.00251	CcSEcCtD
Anastrozole—Arthralgia—Sorafenib—thyroid cancer	0.0015	0.0025	CcSEcCtD
Anastrozole—Myalgia—Sorafenib—thyroid cancer	0.0015	0.0025	CcSEcCtD
Anastrozole—Pulmonary embolism—Epirubicin—thyroid cancer	0.00149	0.00249	CcSEcCtD
Anastrozole—Vaginal inflammation—Epirubicin—thyroid cancer	0.00149	0.00249	CcSEcCtD
Anastrozole—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.00149	0.00249	CcSEcCtD
Anastrozole—Dry mouth—Sorafenib—thyroid cancer	0.00147	0.00245	CcSEcCtD
Anastrozole—Diarrhoea—Vandetanib—thyroid cancer	0.00146	0.00243	CcSEcCtD
Anastrozole—Ulcer—Doxorubicin—thyroid cancer	0.00146	0.00243	CcSEcCtD
Anastrozole—Influenza like illness—Epirubicin—thyroid cancer	0.00145	0.00241	CcSEcCtD
Anastrozole—Bone pain—Doxorubicin—thyroid cancer	0.00144	0.0024	CcSEcCtD
Anastrozole—Anaphylactic shock—Sorafenib—thyroid cancer	0.00144	0.0024	CcSEcCtD
Anastrozole—Infection—Sorafenib—thyroid cancer	0.00143	0.00238	CcSEcCtD
Anastrozole—Inflammation—Doxorubicin—thyroid cancer	0.00142	0.00237	CcSEcCtD
Anastrozole—Dizziness—Vandetanib—thyroid cancer	0.00141	0.00235	CcSEcCtD
Anastrozole—Vaginal infection—Epirubicin—thyroid cancer	0.00141	0.00235	CcSEcCtD
Anastrozole—Neuropathy—Epirubicin—thyroid cancer	0.0014	0.00233	CcSEcCtD
Anastrozole—Neck pain—Doxorubicin—thyroid cancer	0.0014	0.00233	CcSEcCtD
Anastrozole—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.00138	0.0023	CcSEcCtD
Anastrozole—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00138	0.0023	CcSEcCtD
Anastrozole—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00138	0.0023	CcSEcCtD
Anastrozole—Anorexia—Sorafenib—thyroid cancer	0.00137	0.00229	CcSEcCtD
Anastrozole—Vomiting—Vandetanib—thyroid cancer	0.00136	0.00226	CcSEcCtD
Anastrozole—Neoplasm—Epirubicin—thyroid cancer	0.00135	0.00225	CcSEcCtD
Anastrozole—Rash—Vandetanib—thyroid cancer	0.00134	0.00224	CcSEcCtD
Anastrozole—Dermatitis—Vandetanib—thyroid cancer	0.00134	0.00224	CcSEcCtD
Anastrozole—Influenza like illness—Doxorubicin—thyroid cancer	0.00134	0.00223	CcSEcCtD
Anastrozole—Headache—Vandetanib—thyroid cancer	0.00134	0.00223	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00131	0.00219	CcSEcCtD
Anastrozole—Hypertonia—Epirubicin—thyroid cancer	0.00131	0.00218	CcSEcCtD
Anastrozole—Vaginal infection—Doxorubicin—thyroid cancer	0.0013	0.00217	CcSEcCtD
Anastrozole—Neuropathy—Doxorubicin—thyroid cancer	0.00129	0.00216	CcSEcCtD
Anastrozole—Dyspnoea—Sorafenib—thyroid cancer	0.00128	0.00214	CcSEcCtD
Anastrozole—Nausea—Vandetanib—thyroid cancer	0.00127	0.00211	CcSEcCtD
Anastrozole—Dyspepsia—Sorafenib—thyroid cancer	0.00127	0.00211	CcSEcCtD
Anastrozole—Decreased appetite—Sorafenib—thyroid cancer	0.00125	0.00209	CcSEcCtD
Anastrozole—Thrombophlebitis—Epirubicin—thyroid cancer	0.00125	0.00208	CcSEcCtD
Anastrozole—Neoplasm—Doxorubicin—thyroid cancer	0.00125	0.00208	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00124	0.00207	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00124	0.00207	CcSEcCtD
Anastrozole—Fatigue—Sorafenib—thyroid cancer	0.00124	0.00207	CcSEcCtD
Anastrozole—Constipation—Sorafenib—thyroid cancer	0.00123	0.00205	CcSEcCtD
Anastrozole—Pain—Sorafenib—thyroid cancer	0.00123	0.00205	CcSEcCtD
Anastrozole—Hypertonia—Doxorubicin—thyroid cancer	0.00121	0.00202	CcSEcCtD
Anastrozole—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00118	0.00196	CcSEcCtD
Anastrozole—Hot flush—Epirubicin—thyroid cancer	0.00116	0.00193	CcSEcCtD
Anastrozole—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00116	0.00193	CcSEcCtD
Anastrozole—Increased appetite—Epirubicin—thyroid cancer	0.00115	0.00192	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00115	0.00192	CcSEcCtD
Anastrozole—Menopausal symptoms—Epirubicin—thyroid cancer	0.00115	0.00191	CcSEcCtD
Anastrozole—Urticaria—Sorafenib—thyroid cancer	0.00114	0.00191	CcSEcCtD
Anastrozole—Abdominal pain—Sorafenib—thyroid cancer	0.00114	0.0019	CcSEcCtD
Anastrozole—Body temperature increased—Sorafenib—thyroid cancer	0.00114	0.0019	CcSEcCtD
Anastrozole—Dermatitis bullous—Epirubicin—thyroid cancer	0.00113	0.00189	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00112	0.00186	CcSEcCtD
Anastrozole—Cerebrovascular accident—Epirubicin—thyroid cancer	0.0011	0.00184	CcSEcCtD
Anastrozole—Lethargy—Epirubicin—thyroid cancer	0.0011	0.00184	CcSEcCtD
Anastrozole—Osteoarthritis—Epirubicin—thyroid cancer	0.00108	0.0018	CcSEcCtD
Anastrozole—Hot flush—Doxorubicin—thyroid cancer	0.00107	0.00178	CcSEcCtD
Anastrozole—Increased appetite—Doxorubicin—thyroid cancer	0.00106	0.00178	CcSEcCtD
Anastrozole—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00106	0.00177	CcSEcCtD
Anastrozole—Hypersensitivity—Sorafenib—thyroid cancer	0.00106	0.00177	CcSEcCtD
Anastrozole—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00105	0.00175	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00103	0.00172	CcSEcCtD
Anastrozole—Asthenia—Sorafenib—thyroid cancer	0.00103	0.00172	CcSEcCtD
Anastrozole—Mood swings—Epirubicin—thyroid cancer	0.00102	0.00171	CcSEcCtD
Anastrozole—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00102	0.0017	CcSEcCtD
Anastrozole—Lethargy—Doxorubicin—thyroid cancer	0.00102	0.0017	CcSEcCtD
Anastrozole—Pruritus—Sorafenib—thyroid cancer	0.00102	0.0017	CcSEcCtD
Anastrozole—Osteoarthritis—Doxorubicin—thyroid cancer	0.001	0.00167	CcSEcCtD
Anastrozole—Liver function test abnormal—Epirubicin—thyroid cancer	0.000998	0.00167	CcSEcCtD
Anastrozole—Diarrhoea—Sorafenib—thyroid cancer	0.000984	0.00164	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000974	0.00162	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000954	0.00159	CcSEcCtD
Anastrozole—Dizziness—Sorafenib—thyroid cancer	0.000951	0.00159	CcSEcCtD
Anastrozole—Mood swings—Doxorubicin—thyroid cancer	0.000948	0.00158	CcSEcCtD
Anastrozole—Dysphagia—Epirubicin—thyroid cancer	0.000935	0.00156	CcSEcCtD
Anastrozole—Influenza—Epirubicin—thyroid cancer	0.000935	0.00156	CcSEcCtD
Anastrozole—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000924	0.00154	CcSEcCtD
Anastrozole—Vomiting—Sorafenib—thyroid cancer	0.000914	0.00153	CcSEcCtD
Anastrozole—Angina pectoris—Epirubicin—thyroid cancer	0.00091	0.00152	CcSEcCtD
Anastrozole—Rash—Sorafenib—thyroid cancer	0.000907	0.00151	CcSEcCtD
Anastrozole—Dermatitis—Sorafenib—thyroid cancer	0.000906	0.00151	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000901	0.0015	CcSEcCtD
Anastrozole—Headache—Sorafenib—thyroid cancer	0.000901	0.0015	CcSEcCtD
Anastrozole—Bronchitis—Epirubicin—thyroid cancer	0.000899	0.0015	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000882	0.00147	CcSEcCtD
Anastrozole—Influenza—Doxorubicin—thyroid cancer	0.000865	0.00144	CcSEcCtD
Anastrozole—Dysphagia—Doxorubicin—thyroid cancer	0.000865	0.00144	CcSEcCtD
Anastrozole—Nausea—Sorafenib—thyroid cancer	0.000854	0.00143	CcSEcCtD
Anastrozole—Weight increased—Epirubicin—thyroid cancer	0.000851	0.00142	CcSEcCtD
Anastrozole—Weight decreased—Epirubicin—thyroid cancer	0.000846	0.00141	CcSEcCtD
Anastrozole—Angina pectoris—Doxorubicin—thyroid cancer	0.000842	0.00141	CcSEcCtD
Anastrozole—Bronchitis—Doxorubicin—thyroid cancer	0.000832	0.00139	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000826	0.00138	CcSEcCtD
Anastrozole—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000817	0.00136	CcSEcCtD
Anastrozole—Jaundice—Epirubicin—thyroid cancer	0.000812	0.00136	CcSEcCtD
Anastrozole—Urinary tract infection—Epirubicin—thyroid cancer	0.00081	0.00135	CcSEcCtD
Anastrozole—Sweating—Epirubicin—thyroid cancer	0.000799	0.00133	CcSEcCtD
Anastrozole—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000788	0.00131	CcSEcCtD
Anastrozole—Weight increased—Doxorubicin—thyroid cancer	0.000787	0.00131	CcSEcCtD
Anastrozole—Weight decreased—Doxorubicin—thyroid cancer	0.000782	0.00131	CcSEcCtD
Anastrozole—Sinusitis—Epirubicin—thyroid cancer	0.000782	0.0013	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000764	0.00128	CcSEcCtD
Anastrozole—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000756	0.00126	CcSEcCtD
Anastrozole—Haemoglobin—Epirubicin—thyroid cancer	0.000752	0.00125	CcSEcCtD
Anastrozole—Jaundice—Doxorubicin—thyroid cancer	0.000752	0.00125	CcSEcCtD
Anastrozole—Rhinitis—Epirubicin—thyroid cancer	0.00075	0.00125	CcSEcCtD
Anastrozole—Urinary tract infection—Doxorubicin—thyroid cancer	0.000749	0.00125	CcSEcCtD
Anastrozole—Hepatitis—Epirubicin—thyroid cancer	0.000748	0.00125	CcSEcCtD
Anastrozole—Haemorrhage—Epirubicin—thyroid cancer	0.000748	0.00125	CcSEcCtD
Anastrozole—Pharyngitis—Epirubicin—thyroid cancer	0.000742	0.00124	CcSEcCtD
Anastrozole—Sweating—Doxorubicin—thyroid cancer	0.000739	0.00123	CcSEcCtD
Anastrozole—Oedema peripheral—Epirubicin—thyroid cancer	0.000737	0.00123	CcSEcCtD
Anastrozole—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000729	0.00122	CcSEcCtD
Anastrozole—Sinusitis—Doxorubicin—thyroid cancer	0.000723	0.00121	CcSEcCtD
Anastrozole—Erythema multiforme—Epirubicin—thyroid cancer	0.000707	0.00118	CcSEcCtD
Anastrozole—Haemoglobin—Doxorubicin—thyroid cancer	0.000696	0.00116	CcSEcCtD
Anastrozole—Rhinitis—Doxorubicin—thyroid cancer	0.000694	0.00116	CcSEcCtD
Anastrozole—Haemorrhage—Doxorubicin—thyroid cancer	0.000692	0.00115	CcSEcCtD
Anastrozole—Hepatitis—Doxorubicin—thyroid cancer	0.000692	0.00115	CcSEcCtD
Anastrozole—Pharyngitis—Doxorubicin—thyroid cancer	0.000687	0.00115	CcSEcCtD
Anastrozole—Oedema peripheral—Doxorubicin—thyroid cancer	0.000682	0.00114	CcSEcCtD
Anastrozole—Alopecia—Epirubicin—thyroid cancer	0.000661	0.0011	CcSEcCtD
Anastrozole—Erythema multiforme—Doxorubicin—thyroid cancer	0.000654	0.00109	CcSEcCtD
Anastrozole—Erythema—Epirubicin—thyroid cancer	0.000651	0.00109	CcSEcCtD
Anastrozole—Tension—Epirubicin—thyroid cancer	0.000639	0.00107	CcSEcCtD
Anastrozole—Dysgeusia—Epirubicin—thyroid cancer	0.000638	0.00106	CcSEcCtD
Anastrozole—Nervousness—Epirubicin—thyroid cancer	0.000632	0.00106	CcSEcCtD
Anastrozole—Back pain—Epirubicin—thyroid cancer	0.00063	0.00105	CcSEcCtD
Anastrozole—Alopecia—Doxorubicin—thyroid cancer	0.000612	0.00102	CcSEcCtD
Anastrozole—Ill-defined disorder—Epirubicin—thyroid cancer	0.000604	0.00101	CcSEcCtD
Anastrozole—Erythema—Doxorubicin—thyroid cancer	0.000603	0.00101	CcSEcCtD
Anastrozole—Anaemia—Epirubicin—thyroid cancer	0.000602	0.001	CcSEcCtD
Anastrozole—Tension—Doxorubicin—thyroid cancer	0.000591	0.000986	CcSEcCtD
Anastrozole—Dysgeusia—Doxorubicin—thyroid cancer	0.00059	0.000984	CcSEcCtD
Anastrozole—Malaise—Epirubicin—thyroid cancer	0.000587	0.00098	CcSEcCtD
Anastrozole—Nervousness—Doxorubicin—thyroid cancer	0.000585	0.000976	CcSEcCtD
Anastrozole—Leukopenia—Epirubicin—thyroid cancer	0.000583	0.000972	CcSEcCtD
Anastrozole—Back pain—Doxorubicin—thyroid cancer	0.000583	0.000972	CcSEcCtD
Anastrozole—Cough—Epirubicin—thyroid cancer	0.000568	0.000948	CcSEcCtD
Anastrozole—Hypertension—Epirubicin—thyroid cancer	0.000562	0.000938	CcSEcCtD
Anastrozole—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000559	0.000933	CcSEcCtD
Anastrozole—Anaemia—Doxorubicin—thyroid cancer	0.000557	0.000929	CcSEcCtD
Anastrozole—Myalgia—Epirubicin—thyroid cancer	0.000554	0.000925	CcSEcCtD
Anastrozole—Chest pain—Epirubicin—thyroid cancer	0.000554	0.000925	CcSEcCtD
Anastrozole—Arthralgia—Epirubicin—thyroid cancer	0.000554	0.000925	CcSEcCtD
Anastrozole—Anxiety—Epirubicin—thyroid cancer	0.000552	0.000922	CcSEcCtD
Anastrozole—Discomfort—Epirubicin—thyroid cancer	0.000548	0.000914	CcSEcCtD
Anastrozole—Malaise—Doxorubicin—thyroid cancer	0.000543	0.000906	CcSEcCtD
Anastrozole—Dry mouth—Epirubicin—thyroid cancer	0.000542	0.000905	CcSEcCtD
Anastrozole—Leukopenia—Doxorubicin—thyroid cancer	0.000539	0.0009	CcSEcCtD
Anastrozole—Confusional state—Epirubicin—thyroid cancer	0.000536	0.000894	CcSEcCtD
Anastrozole—Anaphylactic shock—Epirubicin—thyroid cancer	0.000531	0.000887	CcSEcCtD
Anastrozole—Oedema—Epirubicin—thyroid cancer	0.000531	0.000887	CcSEcCtD
Anastrozole—Infection—Epirubicin—thyroid cancer	0.000528	0.000881	CcSEcCtD
Anastrozole—Cough—Doxorubicin—thyroid cancer	0.000526	0.000877	CcSEcCtD
Anastrozole—Hypertension—Doxorubicin—thyroid cancer	0.00052	0.000868	CcSEcCtD
Anastrozole—Hyperhidrosis—Epirubicin—thyroid cancer	0.000514	0.000857	CcSEcCtD
Anastrozole—Chest pain—Doxorubicin—thyroid cancer	0.000513	0.000856	CcSEcCtD
Anastrozole—Arthralgia—Doxorubicin—thyroid cancer	0.000513	0.000856	CcSEcCtD
Anastrozole—Myalgia—Doxorubicin—thyroid cancer	0.000513	0.000856	CcSEcCtD
Anastrozole—Anxiety—Doxorubicin—thyroid cancer	0.000511	0.000853	CcSEcCtD
Anastrozole—Discomfort—Doxorubicin—thyroid cancer	0.000507	0.000846	CcSEcCtD
Anastrozole—Anorexia—Epirubicin—thyroid cancer	0.000507	0.000845	CcSEcCtD
Anastrozole—Dry mouth—Doxorubicin—thyroid cancer	0.000502	0.000837	CcSEcCtD
Anastrozole—Confusional state—Doxorubicin—thyroid cancer	0.000496	0.000827	CcSEcCtD
Anastrozole—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000492	0.00082	CcSEcCtD
Anastrozole—Oedema—Doxorubicin—thyroid cancer	0.000492	0.00082	CcSEcCtD
Anastrozole—Infection—Doxorubicin—thyroid cancer	0.000489	0.000815	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000484	0.000808	CcSEcCtD
Anastrozole—Insomnia—Epirubicin—thyroid cancer	0.000481	0.000802	CcSEcCtD
Anastrozole—Paraesthesia—Epirubicin—thyroid cancer	0.000477	0.000796	CcSEcCtD
Anastrozole—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000475	0.000793	CcSEcCtD
Anastrozole—Dyspnoea—Epirubicin—thyroid cancer	0.000474	0.00079	CcSEcCtD
Anastrozole—Somnolence—Epirubicin—thyroid cancer	0.000472	0.000788	CcSEcCtD
Anastrozole—Anorexia—Doxorubicin—thyroid cancer	0.000469	0.000782	CcSEcCtD
Anastrozole—Dyspepsia—Epirubicin—thyroid cancer	0.000468	0.00078	CcSEcCtD
Anastrozole—Decreased appetite—Epirubicin—thyroid cancer	0.000462	0.000771	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000459	0.000765	CcSEcCtD
Anastrozole—Fatigue—Epirubicin—thyroid cancer	0.000458	0.000764	CcSEcCtD
Anastrozole—Pain—Epirubicin—thyroid cancer	0.000454	0.000758	CcSEcCtD
Anastrozole—Constipation—Epirubicin—thyroid cancer	0.000454	0.000758	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000448	0.000747	CcSEcCtD
Anastrozole—Insomnia—Doxorubicin—thyroid cancer	0.000445	0.000742	CcSEcCtD
Anastrozole—Paraesthesia—Doxorubicin—thyroid cancer	0.000442	0.000737	CcSEcCtD
Anastrozole—Dyspnoea—Doxorubicin—thyroid cancer	0.000438	0.000731	CcSEcCtD
Anastrozole—Feeling abnormal—Epirubicin—thyroid cancer	0.000438	0.000731	CcSEcCtD
Anastrozole—Somnolence—Doxorubicin—thyroid cancer	0.000437	0.000729	CcSEcCtD
Anastrozole—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000435	0.000725	CcSEcCtD
Anastrozole—Dyspepsia—Doxorubicin—thyroid cancer	0.000433	0.000722	CcSEcCtD
Anastrozole—Decreased appetite—Doxorubicin—thyroid cancer	0.000427	0.000713	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000425	0.000708	CcSEcCtD
Anastrozole—Fatigue—Doxorubicin—thyroid cancer	0.000424	0.000707	CcSEcCtD
Anastrozole—Urticaria—Epirubicin—thyroid cancer	0.000422	0.000704	CcSEcCtD
Anastrozole—Pain—Doxorubicin—thyroid cancer	0.000421	0.000702	CcSEcCtD
Anastrozole—Constipation—Doxorubicin—thyroid cancer	0.000421	0.000702	CcSEcCtD
Anastrozole—Abdominal pain—Epirubicin—thyroid cancer	0.00042	0.000701	CcSEcCtD
Anastrozole—Body temperature increased—Epirubicin—thyroid cancer	0.00042	0.000701	CcSEcCtD
Anastrozole—Feeling abnormal—Doxorubicin—thyroid cancer	0.000405	0.000676	CcSEcCtD
Anastrozole—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000402	0.000671	CcSEcCtD
Anastrozole—Hypersensitivity—Epirubicin—thyroid cancer	0.000392	0.000653	CcSEcCtD
Anastrozole—Urticaria—Doxorubicin—thyroid cancer	0.000391	0.000652	CcSEcCtD
Anastrozole—Body temperature increased—Doxorubicin—thyroid cancer	0.000389	0.000649	CcSEcCtD
Anastrozole—Abdominal pain—Doxorubicin—thyroid cancer	0.000389	0.000649	CcSEcCtD
Anastrozole—Asthenia—Epirubicin—thyroid cancer	0.000381	0.000636	CcSEcCtD
Anastrozole—Pruritus—Epirubicin—thyroid cancer	0.000376	0.000627	CcSEcCtD
Anastrozole—Diarrhoea—Epirubicin—thyroid cancer	0.000364	0.000607	CcSEcCtD
Anastrozole—Hypersensitivity—Doxorubicin—thyroid cancer	0.000362	0.000604	CcSEcCtD
Anastrozole—Asthenia—Doxorubicin—thyroid cancer	0.000353	0.000589	CcSEcCtD
Anastrozole—Dizziness—Epirubicin—thyroid cancer	0.000351	0.000586	CcSEcCtD
Anastrozole—Pruritus—Doxorubicin—thyroid cancer	0.000348	0.00058	CcSEcCtD
Anastrozole—Vomiting—Epirubicin—thyroid cancer	0.000338	0.000564	CcSEcCtD
Anastrozole—Diarrhoea—Doxorubicin—thyroid cancer	0.000336	0.000561	CcSEcCtD
Anastrozole—Rash—Epirubicin—thyroid cancer	0.000335	0.000559	CcSEcCtD
Anastrozole—Dermatitis—Epirubicin—thyroid cancer	0.000335	0.000559	CcSEcCtD
Anastrozole—Headache—Epirubicin—thyroid cancer	0.000333	0.000555	CcSEcCtD
Anastrozole—Dizziness—Doxorubicin—thyroid cancer	0.000325	0.000543	CcSEcCtD
Anastrozole—Nausea—Epirubicin—thyroid cancer	0.000316	0.000527	CcSEcCtD
Anastrozole—Vomiting—Doxorubicin—thyroid cancer	0.000313	0.000522	CcSEcCtD
Anastrozole—Rash—Doxorubicin—thyroid cancer	0.00031	0.000517	CcSEcCtD
Anastrozole—Dermatitis—Doxorubicin—thyroid cancer	0.00031	0.000517	CcSEcCtD
Anastrozole—Headache—Doxorubicin—thyroid cancer	0.000308	0.000514	CcSEcCtD
Anastrozole—Nausea—Doxorubicin—thyroid cancer	0.000292	0.000487	CcSEcCtD
